menu
    • menu
    [{"orgOrder":0,"company":"Cambridge University Hospitals NHS Foundation Trust","sponsor":"Cambridge Theranostics Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"UNITED KINGDOM","productType":"Plant Extract\/Herbal","year":"2010","type":"Inapplicable","leadProduct":"Lycopene","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Cambridge University Hospitals NHS Foundation Trust","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Cambridge University Hospitals NHS Foundation Trust \/ Cambridge Theranostics Ltd","highestDevelopmentStatusID":"1","companyTruncated":"Cambridge University Hospitals NHS Foundation Trust \/ Cambridge Theranostics Ltd"},{"orgOrder":0,"company":"LycoRed Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"ISRAEL","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Lycopene","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"LycoRed Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Gel","sponsorNew":"LycoRed Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"LycoRed Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"Sheffield Teaching Hospitals NHS Foundation Trust","sponsor":"Health Education England, Wessex | Manchester Metropolitan University | University of Sheffield","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Lycopene","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Sheffield Teaching Hospitals NHS Foundation Trust","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Sheffield Teaching Hospitals NHS Foundation Trust \/ Health Education England, Wessex | Manchester Metropolitan University | University of Sheffield","highestDevelopmentStatusID":"1","companyTruncated":"Sheffield Teaching Hospitals NHS Foundation Trust \/ Health Education England, Wessex | Manchester Metropolitan University | University of Sheffield"},{"orgOrder":0,"company":"LycoRed Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"ISRAEL","productType":"Plant Extract\/Herbal","year":"2012","type":"Inapplicable","leadProduct":"Lycopene","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"LycoRed Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"LycoRed Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"LycoRed Ltd. \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals for Lycopene

    Menu

    Lycopene

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Sheffield Teaching Hospitals NHS Foundation Trust

                            Country arrow
                            SupplySide West
                            Not Confirmed

                            Sheffield Teaching Hospitals NHS Foundation Trust

                            Country arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lycopene

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Health Education England, Wessex | Manchester Metropolitan University | University of Sheffield

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effect of Lycopene on Sperm Quality in Men Attending Fertility Clinic

                            Details : Lycopene is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            January 04, 2023

                            Lead Product(s) : Lycopene

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Health Education England, Wessex | Manchester Metropolitan University | University of Sheffield

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            LycoRed Ltd.

                            Country arrow
                            SupplySide West
                            Not Confirmed

                            LycoRed Ltd.

                            Country arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lycopene

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study to Evaluate the Effect of Lycomato on Skin Attributes in Healthy Participants.

                            Details : Lycomato is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            April 14, 2022

                            Lead Product(s) : Lycopene

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            LycoRed Ltd.

                            Country arrow
                            SupplySide West
                            Not Confirmed

                            LycoRed Ltd.

                            Country arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lycopene

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Tomato Extracted Lycopene on Postprandial Oxidation and inflammation in Healthy Weight Men and ...

                            Details : Lycopene is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            August 15, 2012

                            Lead Product(s) : Lycopene

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Cambridge University Hospitals NHS Foundation Trust

                            Country arrow
                            SupplySide West
                            Not Confirmed

                            Cambridge University Hospitals NHS Foundation Trust

                            Country arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lycopene

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Sponsor : Cambridge Theranostics Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            TomVasc - Vascular Effects of Tomato Extract

                            Details : Ateronon is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Myocardial Ischemia.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            April 09, 2010

                            Lead Product(s) : Lycopene

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Cambridge Theranostics Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth